Trial · NCT07899190
COMPARISON OF THE POSTOPERATIVE ANALGESIC EFFECTS OF ULTRASOUND-GUIDED QUADRO-ILIAC PLANE AND TRANSVERSUS ABDOMINIS PLANE BLOCKS IN PATIENTS UNDERGOING TOTAL LAPAROSCOPIC HYSTERECTOMY
NCT07899190, Not applicable, Not yet recruiting, Hitit University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. COMPARISON OF THE POSTOPERATIVE ANALGESIC EFFECTS OF ULTRASOUND-GUIDED QUADRO-ILIAC PLANE AND TRANSVERSUS ABDOMINIS PLANE BLOCKS IN PATIENTS UNDERGOING TOTAL LAPAROSCOPIC HYSTERECTOMY. Trials, record NCT07899190. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899190
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- COMPARISON OF THE POSTOPERATIVE ANALGESIC EFFECTS OF ULTRASOUND-GUIDED QUADRO-ILIAC PLANE AND TRANSVERSUS ABDOMINIS PLANE BLOCKS IN PATIENTS UNDERGOING TOTAL LAPAROSCOPIC HYSTERECTOMY
- NCT number
- NCT07899190
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Hitit University
- Conditions
- Postoperative Pain Following Total Laparoscopic Hysterectomy
- Interventions
- Ultrasound-Guided Bilateral Quadro-Iliac Plane Block, Ultrasound-Guided Bilateral Transversus Abdominis Plane Block
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total Opioid Consumption During the First 24 Postoperative Hours | From the end of surgery to 24 hours postoperatively. | The cumulative dose of opioid analgesics administered during the first 24 hours after surgery, including tramadol delivered via patient-controlled analgesia (PCA) and rescue fentanyl, will be recorded. Total opioid consumption will be expressed in milligrams of morphine equivalents using the conversion method specified in the study protocol. |
| Primary | Postoperative Pain Intensity at Rest | At 0, 1, 3, 6, 12, 18, and 24 hours postoperatively. | Pain intensity at rest will be assessed using the Numerical Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Scores will be recorded at predefined postoperative time points. |
| Primary | Postoperative Pain Intensity During Movement | At 0, 1, 3, 6, 12, 18, and 24 hours postoperatively. | Pain intensity during movement from a lying to a sitting position will be assessed using the Numerical Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). |
| Primary | Quality of Recovery Assessed by QoR-15 | Preoperative baseline (morning of surgery) and 24 hours postoperatively. | Postoperative quality of recovery will be evaluated using the 15-item Quality of Recovery questionnaire (QoR-15). The questionnaire will be administered preoperatively and at 24 hours after surgery. Total scores range from 0 to 150, with higher scores indicating better recovery quality. |
| Primary | Sensory Block Effectiveness Assessed by Pinprick Testing | At 2 and 24 hours postoperatively. | Sensory block effectiveness and distribution will be assessed bilaterally using the pinprick test in the relevant sensory areas. Responses will be scored as 0 (no pain sensation), 1 (reduced pain sensation), or 2 (normal pain sensation). Scores of 0 or 1 will indicate an effective sensory block in the assessed area. |
| Primary | Time to First Postoperative Opioid Analgesic Requirement | During the first 24 hours postoperatively. | The elapsed time from completion of surgery to the first postoperative opioid analgesic requirement will be recorded in minutes. |
| Primary | Postoperative Tramadol Consumption by Time Interval | During postoperative intervals of 0-1, 1-12, and 12-24 hours. | Tramadol consumption administered through patient-controlled analgesia (PCA) will be recorded in milligrams during the postoperative intervals of 0-1, 1-12, and 12-24 hours. |
| Primary | Total Rescue Fentanyl Consumption | During the first 24 hours postoperatively. | The cumulative intravenous fentanyl dose administered as rescue analgesia for postoperative pain, when NRS is 4 or higher, will be recorded in micrograms. |
| Primary | Postoperative Nausea and Vomiting Severity | During the first 24 hours postoperatively. | Postoperative nausea and vomiting (PONV) will be assessed using a four-point scale: 1 = no nausea or vomiting; 2 = nausea only; 3 = one episode of vomiting or persistent nausea; and 4 = two or more episodes of vomiting or severe or persistent retching. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899190
GET https://conductscience.org/api/trials/v1/NCT07899190/registered